NEW YORK – Bio-Techne said Thursday that its Swiss subsidiary Lunaphore is partnering with Nikon Instruments to expand access to spatial biology services in the US.
Lunaphore will work with the recently established Nikon BioImaging Lab in the Boston area, which provides contract imaging, AI-enhanced analysis, and bioassay development services for research and drug discovery, to bring its Comet platform to US-based biotech, pharma, and academic customers.
The Comet technology is an automated, high-throughput, hyperplex tissue profiling platform that detects proteins with standard, non-conjugated antibodies. Nikon customers will gain access to the platform as well as Lunaphore's Horizon image analysis software.
"The deployment of Comet at the Nikon BioImaging Lab ensures that an expanded base of customers and researchers across the US can access the cutting-edge capabilities of our spatial biology solutions," Matt McManus, president of Bio-Techne's diagnostics and genomics segment, said in a statement.
Nikon is "pleased to provide spatial biology assay services using Lunaphore's automated platform for hyperplex immunofluorescence alongside the broad range of imaging solutions we offer with our Nikon microscopes," Fumiki Yanagawa, general manager at the Nikon BioImaging Lab, added.
Minneapolis-based Bio-Techne acquired Lunaphore, which is located in Tolochenaz, Switzerland, last year.